Researchers Develop Breakthrough Technology To Revert Cancer Cells Back To Normal Cells
The research led by Professor Kwang-Hyun Cho at KAIST represents a paradigm shift in cancer therapy. Rather than focusing on the elimination of cancer cells, this innovative approach aims to revert cancer cells to a normal-like state by systematically analyzing their gene networks and differentiation trajectories. This strategy offers a potential solution to the long-standing challenges of treatment resistance and adverse side effects associated with traditional therapies.